Amazing Son-in-law Chen Chapter 3680

For the next two days, a large number of Hongwu’s minions concentrated at the airport and the high-speed railway station.

They carried out various disguises and secretly photographed all the expatriates who entered Jinling in the past two days, and later aggregated the photos to Richard Chen.

More than ten generals from the Hall of Ten Thousand Dragons hid near the factory of Jiu Xuan Pharmaceuticals, screening every suspicious person who appeared there.

However, after arriving in Jinling, Nakamura Junpei and his group did not immediately head to the vicinity of Jiu Xuan Pharmaceutical. They first rented a villa in the outskirts of Jinling and were waiting for the American side to use special channels to give them the instruments and equipment needed for various experiments.

At the same time, the fever for the Jiu Xuan Recycle Pill continued to climb.

Because the reverse research and development had not been successful, the Americans did not dare to renege on the agreement reached between Smith and Ye Chen.

Therefore, the Mayo Centre was still releasing Jimmy’s physical changes to the public every day after taking the Jiu Xuan Zai Zai Pills.

In addition to this, the other four patients who received the Jiu Xuan Zai Zai Pills, after their names and identities were withheld, their treatment process and results, were also released.

The four terminal cancer patients, after receiving the Jiu Xuan Zai Zai Pill, have seen their health improve and their vital signs stabilise, and their remarkable efficacy has made the Jiu Xuan Zai Zai Pill even more highly regarded around the world.

At the same time, Jiu Xuan Pharmaceuticals also opened up the application for free trials in China, and the number of free trials in China was 100.

After all, the FDA spent US$100 million to obtain a mere 20 boxes of Jiu Xuan Zai Zhuan Pills.

This time, Jiu Xuan Pharmaceuticals is taking out more than 600 boxes to promote free trials in the country, and once this news came out, it immediately made the whole country feel better about Jiu Xuan Pharmaceuticals.

This time, Jiu Xuan Pharmaceutical’s application requirements were written very clearly, patients who met the definition of terminal clinical stage must apply for the trial.

A very detailed and well-defined point policy was required to select these one hundred people.

This points policy is determined by a combination of factors.

These include: the patient’s educational status, the patient’s receipt of various commendations, whether the patient has a criminal record, the actual financial situation of the patient’s family, the patient’s family members, etc., all of which have a significant impact on the points awarded.

In theory, patients who are highly educated, highly qualified, have no criminal records, have received repeated commendations but are from poor families, and are also in their young and middle age, with old and young children, are most likely to be elected.

Ye Chen also knows very well that it may not be 100% fair to engage in screening in this way.

People with high education, high quality and no criminal records are understandable, after all, such people naturally have greater contribution as well as value to society, and from the traditional Chinese moral viewpoint, it makes the most sense for good people to live a long life.

What really got the community talking more intensely was why preference was given to those from poorer backgrounds.

There are many people asking online whether people from well-off families don’t have a chance to survive.

To answer this question, Ye Chen compiled a paragraph and had Wei Liang publish it to Jiu Xuan Pharmaceutical’s official microblogging account.

The pa*sage read, “For the same end-stage cancer patients, those with good financial conditions, it may take ten years from the detection of the disease to the development of the end stage; but those with poor financial conditions, it may only take six months from the detection of the disease to the development of the end stage.”

“In other words, patients who are financially well off have gotten themselves a longer survival cycle in the past.”

“So we would prefer that this limited opportunity be given to those patients from poorer families so that they can live longer and so that they can take on more for their families.”